Skip to main content
Clinical Trials/ACTRN12616000789460
ACTRN12616000789460
Completed
Phase 4

Paclitaxel-eluting balloon Versus plain angioplasty balloon for dysfunctional dialysis access: a prospective double-blinded randomized controlled trial

Department of Surgery, Pamela Youde Nethersole Eastern Hospital, Hong Kong0 sites40 target enrollmentJune 16, 2016

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
Dysfunctional haemodialysis access
Sponsor
Department of Surgery, Pamela Youde Nethersole Eastern Hospital, Hong Kong
Enrollment
40
Status
Completed
Last Updated
6 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
June 16, 2016
End Date
April 16, 2019
Last Updated
6 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Department of Surgery, Pamela Youde Nethersole Eastern Hospital, Hong Kong

Eligibility Criteria

Inclusion Criteria

  • Native arteriovenous fistula or prosthetic arteriovenous graft in the upper limb
  • Vascular access actively used for hemodialysis
  • At least 1 previous successful session of hemodialysis via access
  • Clinical signs of failing access due to presence of significant anatomic stenosis
  • Detection of elevated venous pressure during dialysis and/or decreased blood flow
  • Angiographically/sonographically proven venous outflow stenosis \>50%

Exclusion Criteria

  • Patient unable to provide informed consent
  • Patient unable to abide with study follow\-up protocol
  • Patient participating in other relevant or conflicting studies
  • Vascular access circuit placed in the lower extremities
  • Bare metal stent or stent graft placed previously
  • Hemodynamically significant stenosis of the central venous system
  • Metastatic malignancy or other terminal medical condition
  • Limited life expectancy (\<6 months)
  • Blood coagulation disorders
  • Sepsis or active infection

Outcomes

Primary Outcomes

Not specified

Similar Trials